Ovarian cancer: new developments in clear cell carcinoma and hopes for targeted therapy

Until recently, ovarian clear cell carcinoma was recognized by its unique morphology and unfavorable patient outcome primarily due to tumor chemoresistance. Recently, specific molecular characteristics of ovarian clear cell carcinoma, such as PI3CA mutation, ARID1a mutation and MET amplification, ha...

Descripción completa

Detalles Bibliográficos
Autor principal: Yamashita, Yoriko
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2015
Materias:
Review Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4412138/
https://www.ncbi.nlm.nih.gov/pubmed/25583423
http://dx.doi.org/10.1093/jjco/hyu221

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4412138/
https://www.ncbi.nlm.nih.gov/pubmed/25583423
http://dx.doi.org/10.1093/jjco/hyu221

Ejemplares similares